Putting Biotechnology to Work Bioprocess Engineering (1992) / Chapter Skim
Currently Skimming:
5 Needs: What Must Be Done to Meet the Challenges
5 Needs: What Must Be Done to Meet the Challenges
Pages 77-85
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 77... ...
That will facilitate useful communication of bioprocess engineers with the bench scientists who are at the initial discovery stage of biological-product research and development. The situation can be thought of as analogous to process development in the chemical and petrochemical industries, where engineers who are knowledgeable in basic concepts in organic and physical chemistry have fostered innovations in processes developed through interactions of research chemists and engineers.
|
From page 78... ...
It is recommended that future programs incorporate the industry-university interface into formal training activities. Continuing education is especially critical for bioprocess engineering, because of the rapidity of advances in the biological sciences.
|
From page 79... ...
5.1.4 Bioprocess-Equipment Engineers Biochemical engineers are and should be the lead engineers in bioprocess development. They are educated uniquely to span the gap between the biological sciences and process engineering.
|
From page 80... ...
5.1.6 Curriculum Development A unique element in the education of some bioprocess engineers is handson experience in applied microbiology and molecular biology, bioreactor operation, cell culture, bioseparation (chromatography, membranes, and centrifugation) , and basic analytical methods for biological materials and molecules.
|
From page 81... ...
The key bioprocess-engineering issues are consistent with the continuing programs of NSF, although sustained increases in resources will be needed to fund strong programs. The processing of renewable resources and manufacture of value-added products from agricultural commodities require bioprocess-engineering research to address fundamental understanding and development of · Cellulose pretreatment and saccharification systems to convert lignocellulosic materials, as well as coproducts of corn processing, into appropriately priced fermentable sugars and value-added materials.
|
From page 82... ...
Concerted efforts will be particularly important as the regulatory environment for biotechnology products improves and the regulatory process is streamlined. The federal support of fundamental research in bioprocess engineering is essential, and a major increase in federal support is strongly recommended.
|
From page 83... ...
46. 5.3 TECHNOLOGY TRANSFER Technology transfer in biotechnology and bioprocess engineering can include dissemination of published scientific and technical literature related to biotechnology, movement of scientists and engineers between employers, training of scientists and engineers in bioprocessing technology, construction of plants to manufacture biotechnology products, joint ventures of biotechnology businesses, licensing of biotechnology products and bioprocesses, exchange of manufacturing technology, release of technical information with the sale of bioprocessing equipment, technical consulting, transfer of engineering proposals, and transfer of technical information through trade exhibits.
|
From page 84... ...
The committee recommends that the issue of tax incentives be reexamined with an eye to stimulating greater risk investment by industry, improving technology transfer, stimulating university investigators to set priorities in their fundamental research according to technology that industry will use, and promoting international competitiveness in bioprocess technology. The committee strongly recommends that a strategy be developed for fostering an improvement in awareness of the importance of manufacturing technology in the research and university communities through education
|
From page 85... ...
or foreign companies, because the new firms lack the capital and capability for commercial-scale manufacturing or marketing abroad. It is difficult to assess accurately the amount or extent of international biotechnology transfer, investment, and trade and their potential impact on U.S.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.